Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2022-02-10 5:02 pm Sale | 2021-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | JANUS HENDERSON GROUP PLC JHG | 3,133,935 6.200% | -1,357,830![]() (-30.23%) | Filing History |
2022-02-10 12:27 pm Purchase | 2021-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | PRIMECAP MANAGEMENT CO/CA/ | 6,256,991 12.450% | 686,300![]() (+12.32%) | Filing History |
2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | BlackRock Inc. BLK | 3,328,061 6.600% | 596,955![]() (+21.86%) | Filing History |
2022-01-24 10:32 am Purchase | 2021-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | GOLDMAN SACHS GROUP INC GS | 3,057,559 6.100% | 3,057,559![]() (New Position) | Filing History |
2021-12-10 1:18 pm Sale | 2021-11-30 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | FEDERATED HERMES INC. FHI | 1,775,704 3.530% | -841,896![]() (-32.16%) | Filing History |
2021-03-08 11:04 am Purchase | 2009-02-28 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | PRIMECAP MANAGEMENT CO/CA/ | 5,570,691 11.140% | 1,228,200![]() (+28.28%) | Filing History |
2021-02-16 5:04 pm Sale | 2020-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | BAKER BROS. ADVISORS LP | 2,314,873 5.200% | -393,327![]() (-14.52%) | Filing History |
2021-02-16 4:39 pm Sale | 2020-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | RA Capital Management, L.P. | 4,179,067 9.500% | -1,243,245![]() (-22.93%) | Filing History |
2021-02-12 3:20 pm Purchase | 2020-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | FEDERATED HERMES INC. FHI | 2,617,600 5.920% | 2,617,600![]() (New Position) | Filing History |
2021-02-12 12:31 pm Sale | 2020-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | James E. Flynn | 2,721,203 6.160% | -1,568,088![]() (-36.56%) | Filing History |
2021-02-12 12:02 pm Purchase | 2009-02-28 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | PRIMECAP MANAGEMENT CO/CA/ | 4,342,491 9.820% | 799,900![]() (+22.58%) | Filing History |
2021-02-11 5:11 pm Purchase | 2020-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | JANUS HENDERSON GROUP PLC JHG | 4,491,765 10.200% | 76,296![]() (+1.73%) | Filing History |
2021-02-04 10:14 am Sale | 2020-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | Wellington Management Group LLP | 2,101,227 4.750% | -1,219,524![]() (-36.72%) | Filing History |
2021-02-01 08:23 am Purchase | 2020-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | BlackRock Inc. BLK | 2,731,106 6.200% | 176,340![]() (+6.90%) | Filing History |